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Abstract 
 
THE COLLABORATIVE REGULATION OF CORTICAL NEURON SUBTYPE 
SPECIFICATION BY TLE4 AND FEZF2 
 
David J. Tastad 
 
Projection neuron subtype identities in the cerebral cortex are 
established through the expression of pan-cortical and subtype-specific 
effector genes, which execute terminal differentiation programs that bestow 
neurons with a glutamatergic neuron phenotype and subtype-specific 
morphology, physiology, and axonal projections. Whether pan-cortical 
glutamatergic and subtype-specific characteristics are regulated by the 
same genes or controlled by distinct programs remains largely unknown. 
Here, I show that the transcriptional corepressor, TLE4, is expressed 
specifically in postmitotic corticothalamic projection neurons, where it 
functions to regulate the molecular, dendritic, and electrophysiological 
characteristics unique to corticothalamic neurons. I also demonstrate that 
TLE4 directly interacts with the forebrain embryonic zinc finger protein, 
FEZF2, within corticothalamic projection neurons to facilitate the 
transcriptional repression of subcerebral projection neuron identity. Through 
the utilization of our novel Fezf2-Bac-EnR transgenic mouse line, I was then 
 
 
vi 
able rescue the molecular defects of corticothalamic neurons in the cortex of 
Tle4 knockout mice and restore the dendritic and electrophysiological 
characteristics of theses neurons. Overall, the work presented provides an 
in-depth investigation into the transcriptional regulation of subtype-specific 
cortical projection neuron identity by Tle4 and Fezf2, thereby contributing 
novel insight into our current understanding of mammalian cortical 
development. 
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Chapter 1: Introduction
 
 The human cerebral cortex is comprised of six distinct layers and 
contains roughly 50 to 65 billion neural and glial cells (Pelvig et al., 2007). It is 
responsible for cognition, perception, and complex behaviors unique to 
humans. The coordinated generation of diverse cortical neuron subtypes, and 
their wiring into functional neural circuits is fundamental for its proper function. 
Both intrinsic (e.g., transcription factor-mediated gene regulation) and extrinsic 
(e.g., environmental and extracellular signals) cues delicately orchestrate these 
complex tasks throughout development. Indeed, mutations in genes regulating 
cortical neuron fate specification and differentiation have been identified as 
causes for neurodevelopmental disorders such as intellectual deficiency and 
autism, and these genes are conserved in mice (Balasubramanian et al., 2011; 
Docker et al., 2013; Willsey et al., 2013; Notwell et al., 2016).  Studying these 
genes in mice allows for genetic gain and loss-of-function studies that have 
proven instrumental in gaining a deeper understanding of mammalian cortical 
development. Although we and others have begun to elucidate key 
transcriptional regulators directly involved in the terminal differentiation and 
subtype specification of cortical projection neurons, the molecular logic for this 
remains largely unknown. 
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Radial Glial Cells of the Cerebral Cortex 
Embryonic neural progenitor cells (NPCs) were initially described in the 
19th century by Dr. Golgi and Dr. Ramón y Cajal and are now known to be the 
progenitor cells that give rise to the neurons and glia that make up the 
mammalian central nervous system. The NPCs of the developing cerebral 
cortex have long been studied and were termed radial glial cells (RGCs) in 
1971 by Dr. Pasko Rakic, reflecting their radial orientation in the developing 
telencephalon and their non-mature glial cell-like morphology (Rakic 1971a; 
Rakic 1972). RGCs occupy the cortical ventricular zone (VZ), where they are 
structurally and genetically primed to produce excitatory glutamatergic 
projection neurons in early development, and then produce astrocytes and 
oligodendrocytes later in development (Figure 1-1). Initially, early NPCs in the 
VZ undergo multiple rounds of symmetric cell divisions; this expands the 
overall RGC population (Figure 1-1). RGCs will then divide asymmetrically to 
produce one intermediate progenitor cell (IPC) which will occupy the 
subventricular zone (SVZ), and one RGC that will remain in the VZ (Figure 1-
1). The IPC will ultimately divide and terminally differentiate into multiple types 
of excitatory projection neurons that will migrate into the developing cortical 
plate of the neocortex. (Figure 1-1). Thus, RGCs must maintain an intricate 
balance between proliferation and differentiation to generate the correct 
number of projection neurons and glial cells. 
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Figure 1-1: Schematic of embryonic neuro- and gliogenesis of the cortex. 
Embryonic neuroepithelial (NE) cells of the neural tube give rise to radial glial cells, 
which first differentiate into neurons and then into astrocytes. The neurogenesis 
“window” extends approximately from E11 to E18. nIPC, neurogenic intermediate 
progenitor cell; oIPC, oligodendrogenic intermediate progenitor cell. This figure is 
representative of embryonic neurogenesis in the mouse. (Kriegstein & Alvarez-
Buylla, 2009). 
 
 RGC’s have a unique structure, unlike most neurons they extend two 
processes from their cell bodies, one long basal process which reaches the 
pial surface and one much shorter apical process that descends to the 
ventricular surface. This distinct morphological characteristic of RGCs is 
fundamental to the proper development of the cerebral cortex. The central 
role of the apical process is to regulate the balance between proliferation and 
differentiation. Multiple studies have begun to uncover the critical 
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mechanisms involved in this process, such as integrin/laminin mediated end-
feet binding to the ventricular surface, Eph/ephrin signaling cascades 
localized at the apical process, and apical protocadherin adhesive complexes 
(Kadowaki et al., 2007; Nievergall et al., 2012; Ishiuchi et al., 2009). Indeed, 
mutations of proteins in these structures and pathways affect the regulation of 
proliferation versus differentiation and have been implicated in diseases such 
as heterotopias, microcephaly, and macrocephaly (Schmid et al., 2014; 
Bizzotto and Francis 2015).  
The basal processes of RGCs, however, serve a vastly different role in 
cortical development. The basal process constitutes a scaffold for which 
newly born neurons will use to migrate through the SVZ and previously 
formed cortical layers until they reach their final position within the cortical 
plate (Figure 1-1). The absence or perturbation of this basal process causes 
severe defects in neuronal migration, ultimately leading to vast cortical 
malformation (Bizzotto and Francis 2015).  
In addition to the overall structure of RGCs, the tight regulation of 
target-gene expression by transcription factors in RGCs is essential for the 
generation and organization of glutamatergic projection neurons in the cortex 
(Konno et al., 2019; Desmaris et al., 2018; Kroll et al., 2005; Schuurmans et 
al., 2004). Early in cortical developmental, the transcription factor Sox2, 
among others, maintain precursor identity by inhibiting their differentiation, 
thereby expanding the progenitor population (Graham et al., 2003; Mitzutani 
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et al., 2007; Martynoga et al., 2012). As development proceeds, transcription 
factors expressed in cortical RGCs and/or intermediate progenitors (including 
Pax6, Tlx, Dmrt5, Dmrt3, Emx2, Ngn1, and Ngn2) actively promote the 
generation of cortical glutamatergic projection neurons and prevent the 
production of ventral GABAergic neurons (Konno et al., 2019; Desmaris et al., 
2018; Kroll et al., 2005; Schuurmans et al., 2004). Despite many fundamental 
advances in this field, our understanding of the spatial, temporal, and cell 
type-specific mechanisms of these key factors remains incomplete. 
 
Projection Neuron Subtype Specification 
As mentioned earlier, RGCs in the cortical VZ give rise to transient 
intermediate progenitor cells (IPCs), which reside in the SVZ until they 
differentiate into specific cortical projection neurons. Broadly, excitatory 
projection neurons of the mammalian cerebral cortex can be classified into 3 
major subtypes based on where they project their axons. Corticocortical 
neurons project axons to the ipsilateral (intracortical) or contralateral (callosal) 
cortex and are found in layers 2 through 6. Corticothalamic neurons reside in 
layer 6 and extend axons into the thalamus. They are essential in sensory 
processing, and their dysfunction has been implicated in epilepsy (Mattson, 
2003). Subcerebral neurons project axons into the midbrain, hindbrain, and 
spinal cord, and are confined to layer 5 (O'Leary and Koester, 1993). This 
subtype includes corticospinal motor neurons, which are clinically important 
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neurons that degenerate in Amyotrophic Lateral Sclerosis and are damaged 
in spinal cord injury (Grosskreutz et al., 2006; Habert et al., 2007). 
The development of distinct cortical projection neuron subtypes relies 
heavily on a network of transcription factors that mostly act by cross inhibiting 
the expression of each other. For example, the zinc-finger transcription factor, 
Fezf2, is expressed in deep-layer neurons (layers 5 and 6) and is the major cell 
fate-determining gene for subcerebral neurons. FEZF2 represses high-level 
expression of Tbr1 and Satb2 in deep layer neurons, thereby preventing 
alternate corticothalamic and callosal identities (Arlotta et al., 2005; Chen et al., 
2005a; Chen et al., 2008; Chen et al., 2005b; Molyneaux et al., 2005). 
Additionally, TBR1 and SOX5 directly repress high levels of Fezf2 expression 
in layer 6 neurons, thereby repressing subcerebral neuron identity and driving 
corticothalamic neuronal fate (Kwan et al., 2008; Lai et al., 2008; McKenna et 
al., 2011; Han et al., 2011). Another example of transcriptional repression of 
alternative identities is the role of transcription factor SATB2, which is 
specifically expressed in callosal neurons and promote callosal neuron identity 
by repressing genes that are essential for subcerebral axon development 
(Alcamo et al., 2008; Britanova et al., 2008).  
Despite this exciting progresses, recent studies suggest that our 
current understanding of the molecular mechanism for cortical projection 
neuron fate specification and differentiation is incomplete and somewhat 
incorrect. For example, while SATB2 was initially reported to promote callosal 
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neuron identity by repressing expression of genes essential for subcerebral 
axon development (Alcamo et al., 2008; Britanova et al., 2008), it was 
recently shown that SATB2 is also expressed in subcerebral neurons and is 
essential for their fate specification (McKenna et al., 2015). Similarly, although 
Sox5 was reported to promote corticothalamic neuron fate by directly 
repressing Fezf2 expression (Kwan et al., 2008), it has since been found that 
subcerebral neurons and axons are completely missing in Sox5 mutant brains 
(McKenna et al., 2015). Therefore, we must continuously question and 
investigate the intricate mechanisms underlying neuronal fate specification.  
 
The FEZ and TLE protein families 
Transcription factors typically function to either promote or suppress 
the expression of a specific set of target genes, however some transcription 
factors have been shown to do both depending on the context. Most 
transcription factors have DNA-binding domains which will bind either one 
particular DNA sequence, or a slightly variable DNA motif in the genome to 
exert transcriptional regulation. Interestingly, it is not the case that all 
transcriptional regulators bind to DNA directly. Thus, they are termed 
transcriptional coactivators or corepressors.  
Coactivators increase transcription levels primarily by connecting DNA-
binding transcription factors to general transcription machinery and navigating 
these activators through the constraints of chromatin to their target gene 
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(Naar et al., 2001). Corepressors function primarily either through the short-
range quenching of transcriptional activation near the promotor region of 
genes, or through long-range mechanisms by interacting with chromatin 
remodeling machinery to elicit widespread chromatin remodeling thereby 
generating a repressed chromosomal state (Li and Arnosti, 2011; Chen and 
Courey, 2000; Liu and Karmarkar, 2008). Just as transcriptional activators 
and repressors contain highly conserved DNA binding domains to guide them 
to their target sequences, transcriptional coactivators and corepressors 
contain highly conserved domains which direct them to bind other specific 
proteins.  
The Drosophila Groucho (Gro) protein is the prototype for a large 
family of corepressors that are involved in many developmental processes. 
One group within this family is the Transducin-like Enhancer of split (Tle) 
corepressors, which are the mammalian homologues of the Groucho related 
genes (Grg) initially described in Drosophila (Chen et al., 2000). The Tle 
family consists of four transcriptional corepressors (Tle1, Tle2, Tle3, and 
Tle4) and do not bind to DNA directly, but rather are recruited to DNA-bound 
proteins to repress gene expression and are therefore referred to as 
transcriptional corepressors (Chen et al., 2000). Tle family members are 
required for many developmental processes, including lateral inhibition, 
segmentation, sex determination, dorsal/ventral pattern formation, terminal 
pattern formation, and eye development (Chen et al., 2000). All four members 
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of the Tle family contain the highly conserved WD40 repeat domain. This 
domain directly promotes the binding of TLE proteins to transcription factors 
containing an Eh1 or WRPW domain (Courey and Jia, 2001; Smith and 
Jaynes, 1996; Jimenez et al., 1997; Tolkunova et al., 1998). 
The forebrain embryonic zinc finger (FEZ) family is a highly conserved 
family of transcription factors initially discovered in the anterior 
neuroepithelium of Xenopus and zebrafish embryos (Shimizu and Hibi, 2009). 
The vertebrate FEZ family contains two members, Fezf1 and Fezf2. Both 
proteins express six C2H2 Zinc-finger domains and an Engrailed homology 1 
(Eh1) domain. The Zinc-finger domain is a well characterized protein domain 
involved in the direct binding of DNA and was originally characterized in 1987 
by Aaron Klug (Klug and Rhodes 1987). Additionally, Eh1 domains are now 
known to directly interact with the Groucho/TLE family of transcriptional 
corepressors, leading to transcriptional repression (Hashimoto et al., 2000b).  
 
Innovation and Significance   
The research presented here investigates the role of the transcriptional 
co-repressor, Tle4, and the transcription factor Fezf2, in cortical neuron 
subtype specification. Previously, TLE4 has been assumed to be a marker for 
CThPNs based solely on its specific layer 6 expression pattern, but this 
assumption has never been confirmed in a quantitative manner. Additionally, 
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the function of TLE4 in cortical neuron fate specification has never been 
investigated. In this dissertation, I first show quantitatively that TLE4 is highly 
specific to CThPNs through the injection of retrograde tracers into various 
brain regions. Upon confirming the high corticothalamic specificity of TLE4, I 
began to investigate the potential role of TLE4 in the generation, refinement, 
or maintenance of corticothalamic neurons. Through the use of our novel 
transgenic Tle4 knockout mouse line, I was able to meticulously investigate 
the various roles of TLE4 in corticothalamic neurons. I found that TLE4 
functions to regulate the molecular identity, dendritic morphology, and 
electrophysiological properties of corticothalamic projection neurons. The 
research presented here also clarifies a few key misconceptions regarding 
our current understanding of cortical neuron subtype specification. 
Specifically, others have assumed that FEZF2 expression is restricted to 
subcerebral neurons, but here I show that in layer 6 corticothalamic neurons, 
TLE4 directly interacts with FEZF2 to inhibit the expression of genes 
associated with subcerebral neuron identity, to guide the molecular 
refinement of corticothalamic neurons.  
Having a complete understanding of how different cortical projection 
neurons are generated and subsequently wire together to form complex 
functional neural circuits during development will not only provide deep insight 
into the mechanisms of human brain development, but also will reveal the 
biological causes of various developmental and cognitive brain disorders, 
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such as ALS, mental retardation, schizophrenia, and autism. Thus, the results 
from my dissertation research will have fundamental importance in 
developmental biology, stem cell biology, human disease mechanisms, and 
their potential therapies. The text of this dissertation will present, discuss, and 
interpret results from the following research manuscript currently in 
submission for publication: 
 
Tastad D and Tsyporin J, Ma X, Nehme A, Finn T, Huebner L, Liu G, 
Makhamreh A, Gallardo D, Roberts JM, Katzman S, Sestan N, McConnell 
SK, Yang Z, Qiu S, Chen B (2020). Transcriptional repression by FEZF2 
restricts alternative identities of cortical projection neurons. 
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Chapter 2: Transcriptional regulation of subtype-specific projection 
neuron identities in the developing cerebral cortex by FEZF2 and TLE4 
 
Introduction 
Projection neuron subtype identities in the developing cerebral cortex 
are established through the expression of pan-cortical and subtype-specific 
genes, which execute terminal differentiation programs and bestow neurons 
with a glutamatergic phenotype and subtype-specific morphology, physiology, 
and axonal projections. Whether the pan-cortical glutamatergic phenotype 
and subtype-specific characters are regulated by the same genetic program 
or controlled by distinct genes remains largely unknown. In C. elegans, 
expression of terminal effector genes is activated by terminal selector genes, 
which are transcription factors that act in differentiating neurons by binding to 
common cis-regulatory elements in effector genes and activating their 
expression (Hobert & Kratsios 2019). Whether similar mechanisms are 
utilized in developing mammalian brains is unknown, with the exception of the 
corticospinal neurons (CSNs), a subset of subcerebral projection neurons that 
are specified by the transcriptional regulator FEZF2 (Lodato et al.,2014). 
Although recent advances in single-cell RNA-sequencing (scRNA-seq) 
technologies have allowed classification of neurons into different clusters 
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based on gene expression in individual cells (Tasic et al., 2018), neocortical 
excitatory neurons can be broadly classified into 3 major subtypes based on 
where they project axons (Leone et al., 2008). Corticocortical neurons, 
located in layers 2-6, project axons to the ipsilateral (intracortical) or 
contralateral (callosal) cortex.  The subcerebral neurons projecting to the 
thalamus (corticothalamic neurons), mostly reside in layer 6, whereas the 
subcerebral neurons projecting to the midbrain, hindbrain, and spinal cord are 
confined to layer 5B (O’Leary & Koester 1993). Determining the molecular 
mechanisms underlying the differentiation of these neuronal subtypes is 
essential for understanding the regulatory logic of cell fate specification in the 
neocortex. 
Prior studies have identified several genes that broadly specify the 
identities of cortical projection neuron subtypes and revealed that the 
development of these subtypes depends on a network of transcription factors 
that cross-inhibit one another’s expression. The zinc-finger transcription factor 
Fezf2 is expressed in deep-layer neurons. It promotes a subcerebral neuronal 
identity and suppresses expression of subtype-determining genes for 
corticothalamic (Tbr1) and callosal (Satb2) neurons (Chen et al., 2005; Chen 
et al., 2008; Chen J et al., 2005; Molyneaux et al., 2005). Bcl11b, also known 
as Ctip2, encodes a zinc-finger transcription factor expressed at high levels in 
layer 5 subcerebral neurons and at low levels in layer 6 corticothalamic 
neurons (McKenna et al., 2011). It regulates extension and fasciculation of 
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subcerebral axons (Arlotta et al., 2005). Tbr1 and Sox5 are both expressed at 
high levels in corticothalamic projection neurons. They promote a 
corticothalamic neuronal fate and directly repress Fezf2 expression and 
subcerebral identity in layer 6 neurons (McKenna et al., 2011; Lai et al., 2008; 
Han et al., 2011; Kwan et el., 2008). Satb2 was initially reported to be 
specifically expressed in callosal neurons, where it promotes a callosal 
neuron identity by repressing genes including Bcl11b that are essential for 
subcerebral axon development (Alcamo et al., 2008; Britanova et al., 2008). 
Recent studies show Satb2 is also expressed in subcerebral neurons and is 
required for their fate specification (Leone et al., 2015; McKenna et al., 2015).  
Despite the identification of these critical transcription factors, the 
molecular logic for cortical neuron subtype specification remains elusive. 
Fezf2 has been the prototypic transcription factor for studying this process in 
subcerebral neurons. A recent study reported that Fezf2 directly activates the 
expression of genes conferring glutamatergic and subcerebral neuronal 
identity, and represses genes associated with GABAergic and callosal neuron 
phenotypes, suggesting that, similar to C. elegans neurons (Hobert & Kratsios 
2019), the subtype identities of cortical excitatory neurons are specified by 
terminal selector genes (Lodato et al., 2014). However, the ability of Fezf2 to 
directly activate the expression of terminal effector genes has not been 
rigorously tested. Fezf2 is expressed in both radial glial cells (RGCs) and in 
postmitotic neurons (Chen et al., 2005; Chen et al., 2008; Chen J et al., 2005; 
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Molyneaux et al., 2005; Guo et al., 2013), and it is unclear whether Fezf2 is 
required in RGCs or in newly-generated neurons to specify a subcerebral 
neuronal fate. The N-terminal of FEZF2 protein contains an Engrailed 
Homology domain (EH1), which is known to recruit the Transducin-Like 
Enhancer of Split (TLE) family transcriptional co-repressors (Hashimoto et al., 
2000). It remains to be determined if FEZF2 functions as a transcriptional 
repressor, an activator, or both, during cortical development. Finally, previous 
studies and recent scRNA-seq analyses revealed that, in addition to 
subcerebral neurons, Fezf2 is expressed in corticothalamic and deep-layer 
callosal neurons (Tasic et al., 2018; Molyneaux et al., 2007; Clare et al., 
2017; Tantrigama et al., 2016). If Fezf2 is the terminal selector gene for 
subcerebral neurons, what is the function of Fezf2 in these other cell types?  
Here we address these questions and demonstrate that Fezf2 
functions as a selective repressor in multiple neuronal subtypes to repress the 
expression of genes associated with alternate subtypes. We show that in 
CThPNs, FEZF2 and TLE4 co-regulate the molecular differentiation, dendritic 
morphology, and function of these neurons. Together with previous studies, 
our results suggest that distinct genetic programs act sequentially to regulate 
the differentiation of projection neurons, with genes expressed in progenitor 
cells specifying the pan-cortical glutamatergic phenotype, and subtype-
specifying transcription factors functioning in postmitotic cells to selectively 
repress the expression of genes associated with alternate subtype identities.  
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Results 
Fezf2 is required in postmitotic neurons to regulate the development of 
both subcerebral and corticothalamic identities 
To determine whether Fezf2 acts in cortical RGCs or in postmitotic 
neurons to specify projection neuron subtype identities, we generated Fezf2 
conditional knockout mice (Fezf2 cko) using a Fezf2Flox allele (Shim et al., 
2012) and the NexCre allele (Goebbels et al., 2006) to delete Fezf2 in 
postmitotic neurons. Western blot analysis using a C-terminal FEZF2 
antibody revealed that while FEZF2 protein was absent in the Fezf2-/- null 
mutant cortices, a faint band of full-length FEZF2 was detected in the NexCre 
Fezf2Flox/- (Fezf2 cko) cortices, indicating that the recombination was 
incomplete (Figures 1a and 2b). In addition, a smaller 20 kDa band was 
detected in Fezf2 cko cortices, corresponding to the truncated C-terminal half 
and DNA binding domain of FEZF2 (Figure 1a and Supplementary Figure 1a-
b).   
We compared cortices from Fezf2 cko mice to Fezf2+/- and Fezf2-/- 
cortices at P0 and P7 (Figures 1b-d and Supplemental Figure 1). The Fezf2- 
null mutant allele contained a PLAP (human placenta alkaline phosphatase) 
knock-in gene under the control of endogenous Fezf2 promoter, and enabled 
us to directly observe the axons from Fezf2-expressing neurons (Chen et 
al.,2015). The phenotypes of Fezf2 cko and Fezf2-/- cortices were similar: (1) 
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the expression of subcerebral neuronal genes including BCL11B and 
BHLHB5 was significantly reduced in layer 5 neurons (Figure 1b,c); (2) 
expression of corticothalamic neuron genes such as TBR1 and genes 
expressed at high levels in the callosal neurons such as SATB2 was 
increased in layer 5 (Supplemental Figure 1c-d), suggesting that subcerebral 
neurons adopted corticothalamic and callosal identities; (3) expression of 
corticothalamic neuronal genes such as TLE4, ZFPM2 (FOG2) and FOXP2 
was decreased in layer 6 neurons (Figure 1b-c, Supplemental Figure 1e-f); 
(4) expression of BCL11B was increased in layer 6, demonstrating that the 
molecular distinction between subcerebral and corticothalamic neurons failed 
to be refined in these cells (Figure 1b-c, Supplemental Figure 1b, 1e-f); (5) 
PLAP+ subcerebral axons were significantly reduced in the pyramidal 
decussation (Figure 1d); and (6) consistent with a previous report (Diao et al., 
2018), PLAP+ corticothalamic axons to the dLGN and other thalamic nuclei 
were severely reduced in both Fezf2 cko and Fezf2-/- mice (Figure 1d).  
Despite these similarities, the phenotypes of Fezf2 cko and Fezf2-/- 
cortices were not identical, likely due to incomplete recombination in Fezf2 
cko mice (Figure 1a). Specifically, Fezf2 cko cortices contained a few 
BCL11B+BHLHB5+ subcerebral neurons (Figure 1b-c) and some PLAP+ 
corticospinal axons were able to project to the pyramidal decussation (Figure 
1d).  However, the similarity between the phenotypes of Fezf2 cko and Fezf2-/- 
mice indicates that Fezf2 is required in postmitotic neurons to regulate the 
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molecular identities and axonal projections of both subcerebral and 
corticothalamic neurons.  
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Figure 1: Fezf2 functions in postmitotic neurons to specify cell identity. 
a. Western Blot showing a reduction of full-length FEZF2 protein (arrow) in the Fezf2 
cko cortices. Empty triangle points to residual FEZF2 protein in the Fezf2 cko 
cortices. Recombined Fezf2flox allele produced a truncated FEZF2 (arrowhead) 
corresponding to the C-terminal half of the protein (see Fig S1a). b-c. Immunostains 
for SOX5, BHLHB5, BCL11B, and TLE4 on sections from P0 Fezf2+/-, Fezf2-/-, and 
Fezf2 cko mice. Cortices were divided into 6 equal bins and the numbers of cells in 
each bin were counted. Scale bars:100 µm. d. Quantifications for marker+ neurons 
per 10,000 µm2 in each bin(width:250µm). n=3 brains/genotype, 3 sections/brain. 
Error bars represent ± SEM. Statistical significance was determined using one-way 
ANOVA followed by Tukey’s t-test (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).      
d. PLAP staining of brain sections of P7 Fezf2-/Flox, Fezf2-/-, and Fezf2 cko mice. The 
top row shows coronal cortical sections, the bottom row shows coronal sections at 
the level of pyramidal decussation. White arrows: dLGN;  *: pyramidal decussation. 
Scale bars: top: 1 mm. bottom: 500 µm. 
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Figure S1. The Fezf2-/- and Fezf2 cko mice show similar molecular defects in 
the cortical projection neurons. 
a. Recombined Fezf2Flox allele encodes a truncated FEZF2 protein containing the 
zinc finger DNA binding domain alone b. Staining using C-terminal FEZF2 antibody 
shows the complete absence of FEZF2 protein in Fezf2-/- mice, and increased 
expression of truncated FEZF2 in layer 6 in Fezf2 cko mice. c. SATB2 expression is 
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increased in deep layers of Fezf2-/- and Fezf2 cko cortices. d. TBR1 is increased in 
layer 5 of Fezf2-/- and Fezf2 cko cortices. e-f. ZFPM2 (e) and FOXP2 (f) expression 
is reduced in layer 6 of Fezf2-/- and Fezf2 cko cortices. Scale bars: 100 µm.  
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FEZF2 functions as a transcriptional repressor to specify cortical 
projection neuron subtypes 
FEZF2 protein consists of an N-terminal half containing an EH1 
domain and other sequences, and a C-terminal half consisting of six C2H2-
type zinc-finger motifs (Hashimoto et al., 2000). Zinc finger motifs are 
involved in DNA binding, and the EH1 domain recruits the TLE family 
transcriptional co-repressors. To test whether FEFZ2 functions as a 
transcriptional repressor, an activator, or both, we generated expression 
plasmids encoding a full-length FEZF2 protein, a chimeric protein consisting 
of the transcriptional repressor domain of the engrailed protein (EnR) fused 
with the DNA-binding domain of FEZF2 (pCAG-Fezf2-EnR), or a chimeric 
protein consisting of the VP16 transcription activator domain (VP16) fused 
with the DNA-binding domain of FEZF2 (pCAG-Fezf2-VP16) (Supplemental 
Figure 2a). We co-electroporated each plasmid with a pCAG-EGFP plasmid 
into the cortical ventricular zone of E15.5 wild-type embryos and examined 
the brains at P5 (Supplemental Figure 2b). In all the electroporated brains, 
GFP+ neurons were located in layers 2/3 and GFP+ callosal axons were 
observed. GFP+ axons were not detectable in the thalamus or pons of brains 
electroporated with the pCAG-EGFP plasmid alone, nor in brains 
electroporated with pFezf2-VP16 plasmids. However, both full-length FEZF2 
and FEZF2-EnR directed layer 2/3 neurons to project GFP+ axons into the 
thalamus and cerebral peduncle (Supplemental Figure 2b).        
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To ascertain whether FEZF2 functions primarily as a transcriptional 
repressor during deep layer neuronal differentiation, we generated a 
transgenic line expressing the FEZF2-EnR chimeric protein using a bacterial 
artificial chromosome (BAC) (Figure 2a). This BAC consisted of a 200kb 
region flanking the Fezf2 gene. We inserted the FEZF2-EnR open reading 
frame at the endogenous Fezf2 translation start site, immediately followed by 
a transcription termination signal. Western blot analysis confirmed that 
endogenous FEZF2 protein was not expressed from the Fezf2-EnR 
transgenic allele (Figure 2b). Immunostaining showed that expression of the 
FEZF2-EnR protein recapitulates that of endogenous Fezf2 (Figure 2c). 
We then determined whether FEZF2-EnR can rescue the defects 
resulting from a loss of Fezf2 by comparing the brains of Fezf2+/-, Fezf2-/-, and 
Fezf2-/-; Fezf2-EnR mice (Figure 2d-i, Supplemental Figures 2c-e and 3). The 
expression patterns of subcerebral neuronal markers such as BCL11B, 
BHLHB5 (Figure 2d-e, g), Tox, Tcerg1, and Ldb2 (Supplemental Figure 3) 
were restored in layer 5 neurons in Fezf2-/-; Fezf2-EnR mice. Similarly, the 
expression patterns of corticothalamic neuronal genes such as TLE4, FOXP2 
(Supplemental Figure 2c-e) and ZFPM2 (data not shown), and of the subplate 
neuronal gene Ctgf (Supplemental Figure 3) were restored. The ectopic 
expression of TBR1 (data not shown), FOSL2 (Supplemental Figure 2c), and 
SATB2 (Figure 2d,f) in layer 5 was no longer detected. Further, PLAP+ axons 
projected into the pyramidal decussation, the dLGN and other thalamic nuclei 
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in the Fezf2-/-; Fezf2-EnR mice (Figure 2i). Thus, the Fezf2-EnR allele fully 
rescued the defects observed in layer 5, layer 6, and subplate neurons in 
Fezf2-/- mice, demonstrating that FEZF2 functions as a transcriptional 
repressor. 
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Figure 2: FEZF2 functions as a transcriptional repressor in cortical 
development. 
a. Strategy for generating the Fezf2-EnR BAC transgenic mouse line. b. Western 
blot analysis of dissected cortices at P7. FEZF2 signal was normalized to GAPDH 
signal in each lane. n = 3 brains per genotype. arrow: FEZF2 protein; empty 
triangles: non-specific bands. c. Immunostaining for FEZF2 on brain sections from 
P7 Fezf2+/-, Fezf2-/-, and Fezf2-/-; Fezf2-EnR (EnR) mice. scale bar: 100 µm. d. 
Immunostaining for BCL11B, SATB2, and BHLHB5 on P7 brain sections. scale bar 
for low magnification: 500 µm. scale bar for high magnification: 100 µm. e-h. 
Quantifications of marker+ cells per 10,000 µm2 in each bin.  Heatmaps show the 
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mean numbers of cells per 10,000 um2 for each bin. n=3 mice per genotype, 3 
sections per brain. In all graphs, error bars represent ± SEM. Statistical significance 
was determined using one-way ANOVA followed by post hoc Tukey’s t-test (*p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001). Binning was shown in d. i. PLAP staining of 
brain sections of P7 Fezf2+/-, Fezf2-/-, Fezf2-/-; EnR mice. The top row shows coronal 
cortical sections, the bottom row shows coronal sections at the level of pyramidal 
decussation. Scale bars: 1 mm for top row, 500 µm for bottom row. arrows: LGN; *: 
pyramidal decussation. 
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Figure S2. FEZF2 functions as a transcriptional repressor during cortical 
development.  
a. Schematic representations of full-length FEZF2 protein, the FEZF2-EnR chimeric 
protein, and the FEZF2-VP16 chimeric protein. blue: the N-terminal half of FEZF2; 
purple: the 6 C2H2-type zinc finger motifs of FEZF2; red: the EnR transcriptional 
repressor domain; green: the VP16 transcriptional activator domain. b. Over-
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expression of full-length FEZF2, FEZF2-EnR, and FEZF2-VP16 into layer 2/3 
neurons by in utero electroporation at E15.5, and the effect on axonal projection was 
assessed at P5 using GFP immunostaining. GFP labeled cells and axons in three 
boxed areas (cortex, thalamus and pontine nuclei) were shown. Scale bar, 200 µm. 
c. Immunostaining of FOXP2, BCL11B, TLE4 and FOSL2 in brains of P7 Fezf2+/-, 
Fezf2-/-, and Fezf2-/-; EnR mice. Scale bars: low mag, 500 µm, high mag 100 µm. d-
e. Quantifications of marker+ cells per 10,000 µm2 per bin. n=3 brains per genotype, 
3 sections per brain. In all graphs, error bars represent ± SEM. Statistical 
significance was determined using one-way ANOVA followed by post hoc Tukey’s t-
test (*p<0.05, **p<0.01, ***p<0.001). Heatmaps show mean numbers of cells per 
10,000 um2 for each bin. 
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Figure S3. In situ hybridization showed that Fezf2-EnR fully rescued the 
molecular defects in cortical projection neurons of the Fezf2-/- mice, and 
prevented increased expression of subcerebral neuronal genes in the Tle4-/- 
mice. 
 
In situ hybridizations for Ctgf, Cryab, Tcerg1l, Ldb2, and Tox on 20 µm thick P7 
coronal sections from wt, Fezf2-/-, Fezf2-/-; EnR, Tle4-/-, Tle4-/-; EnR mice. The fold 
change in expression level in Fezf2-/- cortices compared to wild-type littermate 
controls, and in Tle4-/- cortices compared to wild-type littermate controls is shown in 
the two right columns. sp: Subplate. Scale bars: 200 µm. 
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Subtype-specific genes are mis-regulated in the Fezf2-/- cortices 
To further investigate how FEZF2 regulates projection subtype 
identities, we performed bulk RNA-seq analysis of cortices from P0 Fezf2-/- 
and littermate control Fezf2+/+ mice (n=3 mice for each genotype). The 
expression levels of 390 genes were mis-regulated in the Fezf2-/- cortices 
(P<0.05). 221 genes showed reduced expression and 169 showed increased 
expression. DAVID analysis (https://david.ncifcrf.gov) revealed that the top 
GO terms associated with mis-regulated genes in Fezf2-/- cortices were 
extracellular region, multicellular organism development, collagen fibril 
organization, synapse, and cell junction. We examined the expression of 
these mis-regulated genes in specific subtypes of cortical neurons using the 
DeCoN dataset (www.decon.fas.harvard.edu; Molyneaux et al., 2015), and 
found that 161 of the 221 genes showing reduced expression in Fezf2-/- 
cortices were subtype-specific (c2=256.1, DF=3, P<<0.001): 77 genes were 
enriched in subcerebral neurons, 77 in corticothalamic neurons, and 7 in 
corticocortical neurons. Among the 169 genes showing increased expression 
in Fezf2-/- cortices, 135 were subtype-specific (c2=308.2, DF=3, P<<0.001): 
90 were enriched in corticocortical neurons, 28 in corticothalamic neurons, 
and 17 in subcerebral neurons (Figure 3a). We confirmed the subtype-
specific expression of some of these genes using the Allen Brain Atlas 
(http://developingmouse.brain-map.org/) and performing in situ hybridization 
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(Figure 3b-d). These results suggest that FEZF2 primarily regulates subtype-
specific gene expression. 
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Figure 3: Genes mis-regulated in Fezf2-/- cortices were enriched in projection 
neuron subtype-specific genes. 
a. Left heatmap shows genes with increased expression in Fezf2-/- cortices. Right 
heatmap shows genes with decreased expression in Fezf2-/- cortices. Heatmaps for 
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the mis-regulated genes were generated based on relative expression levels in each 
respective cell type at P1 from the DeCoN dataset. C: callosal neuronal genes; Cth: 
corticothalamic neuronal genes; Sc: subcerebral neuronal genes. b-d. Expression 
patterns detected by in situ hybridizations and fold of change of expression level in 
the Fezf2-/- cortices for the up-regulated callosal neuronal genes, and down-
regulated corticothalamic and subcerebral neuronal genes. All the in situs except 
Kcnh1, Shisa2, Unc5c and Plxn4 were from the Allen Brain Atlas Developing Mouse 
Brain data. 
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TLE4 and FEZF2 are co-expressed in differentiating corticothalamic 
neurons 
The N-terminal of the FEZF2 protein contains an EH1 motif, which 
recruits the TLE family co-repressors (Muhr et al., 2001). A previous study 
reported that Xenopus FEZF2 and TLE4 proteins directly interact with each 
other (Zhang et al., 2014). To determine whether FEZF2 recruits TLE4 to 
regulate the development of deep-layer neurons, we first performed 
immunostaining using antibodies against FEZF2 and TLE4, which revealed 
that the two proteins were co-expressed in layer 6 neurons (Figure 4a).  
To identify the neuronal subtype that expresses TLE4, we performed 
retrograde tracing by injecting fluorescence-conjugated cholera toxin beta 
subunit (CTB) into the thalamus, pyramidal decussation, or contralateral 
cortex (Figure 4b). More than 99% of retrogradely labeled corticothalamic 
neurons expressed TLE4, whereas labeled subcerebral neurons and callosal 
neurons did not (<1%). Thus, TLE4 is specifically expressed in 
corticothalamic neurons. 
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Figure 4: TLE4 and FEZF2 are co-expressed in corticothalamic neurons. 
a. Immunostaining for TLE4 and FEZF2 at E14.5, E16.5 and P0 in WT mice. Low 
mag: single z-plane image, scale bar 50 µm, high mag: maximum z-projection 
image, scale bar 10µm. b. Retrograde tracing and immunostaining show TLE4 is 
expressed in >99% of retrogradely labeled CThPNs in M1 (1034 TLE4+CTB+ /1050 
CTB+ cells), 0% of the traced SCPNs (930 cells), and 0.1% of the CPNs (2 
TLE4+CTB+ among 1783 CTB+ cells). n=3 mice for each injection location, and 3 
sections per brain were quantified.  
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Corticothalamic axons developed normally in the Tle4-/- mice 
To test the function of Tle4 in the specification and differentiation of 
corticothalamic neurons, we generated a Tle4 mutant allele by inserting a 
BGal-ires-Plap cassette into the 4th intron of the Tle4 gene (Supplemental 
Figure 4a). The BGAL and PLAP reporters enabled us to label the cell bodies 
and axons of Tle4 heterozygous and mutant neurons, respectively 
(Supplemental Figure 4b, d). In Tle4+/- brains, BGAL expression recapitulated 
the endogenous pattern of TLE4 expression (Supplemental Figure 4b). 
Immunostaining revealed that TLE4 protein is not present in Tle4-/- mice 
(Supplemental Figure 4c).  In both Tle4+/- and Tle4-/- mice, PLAP+ axons 
extended from cortex to the thalamus, with no obvious difference between 
control and mutant brains (Supplemental Figure 4d). We performed 
anterograde tracing by injecting AAV-mcherry virus into the M1, S1, and V1 
cortical areas, which confirmed that corticothalamic axons developed 
normally in Tle4-/- mice (Supplemental Figure 4e and data not shown). 
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Figure S4. Corticothalamic neurons project axons properly into the thalamus 
of Tle4-/- mice. 
a. Knockout strategy for Tle4 gene. SA-B-Gal-ires-Plap cassette was inserted into 
the intron after exon 4. SA: splicing acceptor; B-Gal: b-galactosidase; ires:internal 
ribosome entry site; Plap: human placental alkaline phosphatase; NLS: nuclear 
localization signal. b. Staining shows that B-GAL recapitulates TLE4 expression in 
the Tle4+/- mice. scale bar:100 µm c. TLE4 protein is not detected by immunostaining 
in the Tle4-/- mice. d. PLAP staining of P7 Tle4+/- and Tle4-/- mice. arrows: corpus 
callosum; arrowheads: thalamus; *: pyramidal decussation. Scale bars: 500µm. AC: 
anterior commissure; ctx: cerebral cortex, CC: corpus callosum, str: striatum, sp: 
septum, hp: hippocampus; hy: hypothalamus; th: thalamus. e. AAV-mCherry was 
injected into primary somatosensory cortex in Tle4+/-  and Tle4-/- mice at P21, brains 
collected at P35. Eight consecutive 50µm sections (I-VIII) shown. Scale bar:1mm.  
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Molecular differentiation of corticothalamic neurons is defective in   
Tle4-/- mice 
We performed RNA-seq analysis of control and Tle4-/- P0 cortices (n=3 
mice for each genotype). 473 genes were mis-regulated in the Tle4-/- cortices 
(P<0.05, student’s t-test). Using the DeCoN dataset 
(http://decon.fas.harvard.edu/), we examined the neuronal subtype-specific 
expression of all mis-regulated genes. Among the 253 genes with reduced 
expression, 27 were associated with corticocortical neurons, 79 were 
specifically expressed in corticothalamic neurons and 18 in subcerebral 
neurons. Among the 220 up-regulated genes, 29 were associated with 
corticocortical neurons, 69 were enriched in subcerebral neurons and 24 in 
corticothalamic neurons (Figure 5a).  
We performed immunohistochemistry and in situ hybridization to 
validate the RNA-seq results. Consistent with the normal corticothalamic 
axons observed in Tle4-/- brains, the expression of TBR1 and SOX5, two 
genes essential for specifying a corticothalamic neuron identity, was not 
significantly affected in mutant mice (Supplemental Figure 5a-b). However, 
the number of BGAL+ neurons was significantly reduced in layer 5 and layer 
6a in Tle4-/- mice (Figure 5b). Expression of other layer 6 neuron markers 
such as ZFPM2 (Figure 5b) and FOXP2 (Supplemental Figure 5c) was also 
significantly reduced.  High expression levels of FEZF2, BCL11B, BHLHB5, 
Ldb2, Tcerg1l, and Tox are normally associated with layer 5 subcerebral 
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neurons, but in Tle4-/- mice, their expression was significantly increased in 
layer 6 (Figure 5c-d and Supplemental Figure 3).  
The reduced numbers of BGAL+, ZFPM2+, and FOXP2+ cells in Tle4-/- 
mice could be due to reduced neuronal production, increased cell death, or 
defective molecular differentiation, while the increased numbers of cells 
expressing BCL11B, FEZF2, and other subcerebral markers in layer 6 could 
be due to a migration defect of layer 5 neurons or the mis-regulation of these 
genes in layer 6 neurons. To ascertain whether the production or migration of 
layer 5 and 6 neurons was affected in Tle4-/- mice, we performed birthdating 
experiments by injecting EdU into pregnant mice on E12.5 or E13.5, and 
analyzing the brains of Tle4-/- and control mice at P7. For both labeling dates, 
we saw no significant change in the number or distribution of EdU+ cells in the 
deep layers of Tle4-/- cortices (Supplemental Figure 6a-b). We then stained 
control and Tle4-/- sections at E14, P0 and P7 with an antibody against 
activated caspase 3 (AC3) and saw no significant difference in the number of 
AC3+ cells between genotypes at any age (Supplemental Figure 6c).  
Together, these results indicate that in Tle4-/- mice, corticothalamic 
neurons were generated in appropriate numbers, migrated to their normal 
laminar destinations, and projected axons to the thalamus. However, the 
molecular differentiation of these neurons was impaired, resulting in the 
expression of genes normally associated with subcerebral neurons. 
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Figure 5. Molecular differentiation of corticothalamic neurons was defective in 
Tle4-/- brains.  
a. RNA-seq revealed that genes with increased expression in Tle4-/- cortices are 
enriched in subcerebral neuronal genes, while those reduced expression were 
enriched in corticothalamic neuronal genes. Left heatmap shows genes increased in 
Tle4-/- cortices. Right heatmap shows genes decreased in Tle4-/- cortices. Heatmaps 
for the mis-regulated genes were generated based on relative expression levels in 
each respective cell type at P1 from the Decon dataset. C: callosal neuronal genes; 
Cth: corticothalamic neuronal genes; Sc: subcerebral neuronal genes. b. 
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Immunostaining of TLE4 or B-GAL and ZFPM2 in the P7 brains, and quantifications 
of the numbers of TLE4+ or B-GAL+, and ZFPM2+ cells by bin, and total cell counts. 
c. Immunostaining of TLE4 or B-GAL, BCL11B, and FEZF2 in the P7 brains, and 
quantifications of the FEZF2+ and BCL11B+FEZF2+ cells by bin, and total cell counts. 
d. Immunostaining of TLE4 or B-GAL, BCL11B, and BHLHB5 in the P7 brains, and 
quantifications of the BCL11B+BHLHB5+ cells n=3 brains per genotype, 3 sections 
per brain. Quantifications of marker+ cells per 10,000 µm2 in each bin. In all graphs, 
error bars represent ± SEM. Statistical significance was determined using unpaired 
student’s t-tests (*p<0.05, **p<0.01, ***p<0.001). Scale bars: low mag, 1 mm, low 
mag, 500 µm.  
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Figure S5. The numbers of TBR1+ and SOX5+ layer 6 neurons were not affected 
in Tle4-/- cortices, while the number of FOXP2+ cells was reduced. 
a. TBR1 staining, quantification by bin and the total numbers of TBR1+ cells in Tle4+/- 
and Tle4-/- cortices. b. SOX5 staining, quantification by bin and the total numbers of 
SOX5+ cells in Tle4+/- and Tle4-/- cortices. c. FOXP2 staining, quantification by bin 
and the total numbers of FOXP2+ cells in Tle4+/+ and Tle4-/- cortices. n=3 brains per 
genotype, 3 sections per brain. Quantifications of marker+ cells per 10,000 µm2 in 
each bin. In all graphs, error bars represent ± SEM. Scale bars: low mag, 500 µm, 
high mag 100 µm.  
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Figure S6. EdU birthdating and apoptosis analysis of the Tle4+/+ and 
Tle4-/- cortices. 
a. EdU was given at E12.5, brains were analyzed at P7. Quantifications show 
the %EdU+ cells per bin, and EdU+ cells per 750 µm wide section. b. EdU was 
given at E13.5, brains were analyzed at P7. Quantifications show the %EdU+ 
cells per bin, and total numbers of EdU+ cells per 500 µm wide section. c. 
Quantifications of AC3+ cells per section at E14.5, P0 and P7. n=3 mice per 
genotype, 3 sections per brain. Statistical significance for quantifications in a-
c were determined using the unpaired student’s t-test (*p<0.05, **p<0.01).  
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Morphological and electrophysiological defects of corticothalamic 
neurons in Tle4-/- mice 
We next investigated whether Tle4 is required for the morphological 
and functional differentiation of corticothalamic neurons. We injected 
retrobeads into the ventral posteromedial nucleus (VPM) of the thalamus 
(Landisman et al., 2007) of Tle4+/+ and Tle4-/- mice (P27-35), and performed 
whole cell patch clamp recordings and morphological analyses on labeled 
corticothalamic neurons in primary somatosensory cortex (S1) (Figure 6a-b). 
Sholl analysis on reconstructed dendritic arbors revealed a significant 
reduction in the branching (F(2,286) = 3.4, p = 0.034) and length (F(2,253) = 7.3, p 
= 0.0009) of dendrites in mutant mice (Figure 6c). Mutant corticothalamic 
neurons also show significantly increased spine density, decreased spine 
head diameter, and increased spine length (Figure 6d).  
Patch clamp recordings revealed that corticothalamic neurons in Tle4-/- 
mice exhibited increased excitability, as demonstrated by an increased 
number of action potentials (AP) firing in response to current steps (Figure 6e, 
F(1,110) = 38.9, p < 0.001); however, the AP threshold was unaffected (Figure 
6f). Mutant corticothalamic neurons showed an increased membrane 
resistance and decreased membrane capacitance (Figure 6g, p < 0.05 for 
both). The amplitude (p = 0.02, K-S test) and frequency (t31 = 2.7, p = 0.011) 
of miniature excitatory postsynaptic currents (mEPSC) were reduced in Tle4-/- 
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mice compared to wild-type mice (Figure 6h), but no significant change in the 
amplitude or frequency of miniature inhibitory postsynaptic currents (mIPSC) 
was observed (Figure 6i). These results collectively indicate that Tle4 is 
critical for the morphological development and function of corticothalamic 
neurons in somatosensory cortex. 
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Figure 6. Tle4-/- mice show disrupted morphological and electrophysiological 
properties in corticothalamic neurons in S1, which were rescued by the Fezf2-
EnR allele.  
a. Schematic illustration of retrobeads injection into VPM of thalamus, and 
preparation of S1 slices for patch clamp recording. b. A brightfield image overlaid 
with bead+ layer 6 corticothalamic neurons. An enlarged view shows a beads+ 
corticothalamic neuron and its morphology revealed by biocytin-avidin-Alexa 488. 
Right, two examples of representative dendritic arbors reconstructed from the beads+ 
corticothalamic neurons in a Tle4+/+ and a Tle4-/- mouse. c. Sholl analysis on the 
dendritic intersection numbers and dendritic length. Left panel shows a significant 
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difference among the genotypes (F(2, 297) = 21.7, p < 0.0001. Tukey’s multiple 
comparison tests: between Tle4+/+ and Tle4-/- mice, p < 0.0001; between Tle4+/+ and 
Tle4-/-; Fezf2-EnR mice, p = 0.96.  ***p < 0.001, between Tle4+/+ and Tle4-/- mice, 
Sidak’s multiple comparison test). Right panel shows dendritic length distribution. 
Genotype has a significant effect (F(2, 253) = 7.54, p = 0.0007. Tukey’s multiple 
comparisons test: between Tle4+/+ and Tle4-/-, p = 0.0006; between Tle4+/+ and Tle4-/-
; Fezf2-EnR, p = 0.42. ****p < 0.0001, between Tle4+/+ and Tle4-/-, Sidak’s multiple 
comparison test). d. Representative images of dendritic spines and their 3-D 
projection images. Compared to the Tle4+/+ neurons, there was a significant increase 
in spine density (**p = 0.007, one way ANOVA with Dunnett’s multiple comparison) 
and spine length (**** p < 0.0001, Kruskal-Wallis test followed by Dunn’s multiple 
comparison test), and a significant decrease in spine head diameter (** p < 0.0013)  
for the Tle4-/- corticothalamic neurons. No significant difference in spine density, 
spine length, or spine head diameter was detected between the corticothalamic 
neurons in Tle4+/+ and Tle4-/-; Fezf2-EnR mice.  e. Representative action potential 
firing responses from a Tle4+/+, Tle4-/-, and a Tle4-/-; Fezf2-EnR corticothalamic 
neuron. Genotype has a significant effect on the current-AP responses (F(2, 165) = 
24.1, p < 0.0001). Compared to Tle4+/+ neurons, Tle4-/- neurons show increased firing 
in response to depolarizing current steps (p < 0.0001, Dunnett’s multiple 
comparison), which was reversed in Tle4-/-; Fezf2-EnR mice (p = 0.14).  f. AP 
threshold did not differ between Tle4+/+ , Tle4-/-, or Tle4-/-; Fezf2-EnR neurons (F(2,32) 
= 2.5, p = 0.09, one-way ANOVA with Dunnett’s multiple comparison). g. Genotype 
has a significant effect on membrane input resistance (F(2,30) = 10.8, p = 0.0003, one-
way ANOVA). Tle4-/- neurons show increased input resistance compared to Tle4+/+ 
neurons (p = 0.0003, Dunnett’s multiple comparison test), which was rescued in 
Tle4-/-; Fezf2-EnR mice (p = 0.87). Genotype has a significant effect on membrane 
capacitance (F(2,33) = 28.0, p < 0.0001). Compared to Tle4+/+ neurons, Tle4-/- neurons 
show decreased membrane capacitance (p = 0.0003, Dunnett’s multiple comparison 
test), which was rescued in Tle4-/-; Fezf2-EnR mice (between Tle4+/+ and Tle4-/-; 
Fezf2-EnR: p = 0.52). h. Left, Representative mEPSC traces from Tle4+/+, Tle4-/-, and 
Tle4-/-; Fezf2-EnR neurons. Right, cumulative plot on mEPSC amplitude. Between 
Tle4+/+ and Tle4-/-, *p < 0.02, Kolmogov-Smirnov test; between Tle4-/- and Tle4-/-; 
Fezf2-EnR, p = 0.57. Inset, a significant decrease in mEPSC frequency in Tle4-/- 
neurons (between Tle4+/+ and Tle4-/-, * p = 0.015, Dunn’s multiple comparison 
following Kruskal-Wallis test) was restored by the Fezf2-EnR allele (between Tle4+/+ 
and Tle4-/-; Fezf2-EnR: p = 0.99, Dunn’s multiple comparison test). i. No significant 
change in mIPSC amplitude and frequency was observed between Tle4+/+ and Tle4-/- 
neurons (cumulative amplitude: p = 0.43; frequency: p = 0.17. Kolmogov-Smirnov 
test.) 
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Expression of FEZF2-EnR rescued the molecular, morphological, and 
functional defects of layer 6 neurons in Tle4-/- cortices 
The co-expression of FEZF2 and TLE4 in corticothalamic neurons 
suggests that they function together in regulating the development of these 
neurons. To test this, we generated Tle4-/-; Fezf2-EnR mice and compared 
them to Tle4+/+ and Tle4-/- mice. The number of B-GAL+ cells in Tle4-/-; Fezf2-
EnR mice was restored to the number of TLE4+ cells seen in Tle4+/+ mice 
(Figure 7a-b). The expression of genes normally enriched in subcerebral 
neurons, such as BCL11B, BHLHB5, Tcerg1l, Ldb2, and Tox, was no longer 
increased in layer 6 neurons in Tle4-/-; Fezf2-EnR mice (Figure 7a, c-f and 
Supplemental Figure 3). However, expression of corticothalamic neuron 
genes, including ZFPM2 and FOXP2, and the subplate gene Ctgf, was not 
restored (Supplemental Figures 3 and 7). These results show that FEZF2 and 
TLE4 function together to prevent the high-level expression of subcerebral 
neuronal genes in corticothalamic neurons. They also suggest that, besides 
serving as a transcriptional co-repressor for FEZF2, TLE4 has additional 
functions in regulating the molecular differentiation of corticothalamic 
neurons. 
We next compared the dendritic morphology and function of 
corticothalamic neurons in Tle4-/-; Fezf2-EnR mice to Tle4+/+ mice (Figure 6). 
Sholl analysis revealed that Fezf2-EnR rescued the decreased dendritic 
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branching (p = 0.96) and length (p = 0.42) observed in Tle4-/- corticothalamic 
neurons (Figure 6c). The changes in spine density (p = 0.88), spine head 
diameter (p = 0.98), and spine length (p = 0.99) were also reversed (Figure 
6d). Patch clamp experiments showed that the Fezf2-EnR allele normalized 
the increased neuronal excitability associated with Tle4-/- neurons (Figure 6e). 
Corticothalamic neurons in Tle4-/-; Fezf2-EnR and wild-type mice showed 
similar membrane resistance (p = 0.53), capacitance (p = 0.87) (Figure 6g), 
and mEPSC amplitude cumulative distribution and frequency (Figure 6h). 
Taken together, these data suggest that FEZF2 and TLE4 together 
regulate the morphological and functional differentiation of corticothalamic 
projection neurons. 
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Figure 7. FEZF2-EnR represses the increased expression of subcerebral 
neuronal genes in the corticothalamic neurons in the Tle4-/- mice. 
a. Immunostaining of TLE4 or B-GAL, BCL11B and BHLHB5 in the cortices of P7 
Tle4+/+, Tle4-/- and Tle4-/-; Fezf2-EnR mice. b. Quantifications of TLE4+ cells in the 
Tle4+/+ cortices and the B-GAL+ cells in Tle4-/- and Tle4-/-; Fezf2-EnR cortices.          
c. Quantifications of the numbers of BCL11B+BHLHB5+ cells. d. Immunostaining of 
TLE4, B-GAL, BCL11B and FEZF2 in the cortices of P7 Tle4+/+, Tle4-/- and Tle4-/-; 
Fezf2-EnR mice. e. Quantifications of the FEZF2+ cells by bin. f. Quantifications of 
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the numbers of FEZF2+BCL11B+ cells. n=3 brains per genotype, 3 sections per 
brain. Quantifications of marker+ cells per 10,000 µm2 in each bin. Heatmaps show 
the mean numbers of cells per 10,000 um2 for each bin. In all graphs, error bars 
represent ± SEM. Statistical significance was determined using one-way ANOVA 
followed by post hoc Tukey’s t-test (*p<0.05, **p<0.01, ***p<0.001). 
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Figure S7. Reduced expression of layer 6 neuronal markers ZFPM2 and FOXP2 
in the Tle4-/- mice were not rescued by the Fezf2-EnR allele. 
a. Immunostaining for TLE4, B-GAL, and ZFPM2 in the cortices of P7 Tle4+/+, Tle4-/- 
and Tle4-/-; Fezf2-EnR mice. b. Immunostaining for TLE4, B-GAL and FOXP2. c. 
Quantifications of the ZFPM2+ cells by bin. d. Quantifications of the FOXP2+ cells by 
bin.  n=3 brains per genotype, 3 sections per brain. Quantifications of marker+ cells 
per 10,000 µm2 in each bin. Heatmaps show the mean numbers of cells per 10,000 
um2 for each bin. In all graphs, error bars represent ± SEM. Statistical significance 
was determined using one-way ANOVA followed by post hoc Tukey’s t-test (*p<0.05, 
**p<0.01, ***p<0.001). 
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Discussion 
Deciphering the molecular logic for establishing neuronal subtype 
identities in the developing cerebral cortex is fundamental to understanding 
how neuronal diversity is established in the mammalian brain. In this study we 
examined the molecular control of two broad classes of cortical projection 
neurons - the corticothalamic and the subcerebral projection neurons - by 
focusing on the function of FEFZ2.  
Prior studies demonstrated that FEFZ2 is a master regulator for CSNs, 
a subpopulation of subcerebral neurons. In Fezf2-/- mice, subcerebral neurons 
were absent, and instead the mutant layer 5b neurons demonstrated the 
molecular features and axonal projection patterns of corticothalamic or 
corticocortical neuron subtypes (Chen et al., 2005; Chen et al., 2008; Chen J 
et al., 2005). Complementing these studies, ectopic expression of Fezf2 in 
late cortical progenitors or upper-layer neurons, or in the progenitors of the 
lateral ganglionic eminence, led to the differentiation of neurons with gene 
expression and axon projections associated with corticothalamic or 
subcerebral neurons(Lodato et al., 2014; Chen et al., 2008; Chen J et al., 
2005; Molyneaux et al., 2005; Rouaux et al., 2010; Rouaux et al., 2013; De la 
Rossa et al., 2013), suggesting that FEZF2 functions as a selector gene for 
subcerebral neurons. To test this, Lodato et al. (2014) performed gene 
expression analyses of cortical progenitors and neurons that over-expressed 
FEZF2, and ChIP-seq analysis of neurospheres that over-expressed FEZF2-
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FLAG. Results from these experiments led the authors to conclude that 
FEZF2 functions as both a transcriptional activator and a repressor. They 
suggested that FEZF2 directly induces CSN glutamatergic identity by 
activating expression of genes including Vglut1 (Slc17a7), and that it inhibits 
a GABAergic fate by repressing the transcription of genes such as Gad1 
(Lodato et al., 2014). They further reported that FEZF2 directly activates 
CSN-specific genes by binding to their proximal promoters and represses 
genes expressed in corticocortical projection neurons (Lodato et al., 2014).   
Here we directly tested whether FEZF2 functions as a transcriptional 
activator, a repressor, or both, by comparing the activities of full-length 
FEZF2, FEZF2-EnR and FEZF2-VP16 chimeric proteins using two different 
assays. Results from both over-expression and rescue experiments showed 
that FEZF2-EnR recapitulated the activity of full-length FEZF2 protein, while 
the FEZF2-VP16 was less relevant in our assays. Thus, in contrast to prior 
work, our studies demonstrate that FEZF2 functions primarily as a 
transcriptional repressor, in context of the formation of corticospinal tract and 
neuronal identity. It is not clear why our results differ so markedly from those 
of Lodato et al. (2014), although it seems possible that ChIP-seq experiments 
may have overestimated the binding sites for FEZF2 in normal cortical 
neurons (Jain et al., 2015; Teytelman et al., 2013).   
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FEZF2 is required for establishing the molecular identity and axonal 
projections of both subcerebral and corticothalamic neurons. In the absence 
of Fezf2, subcerebral neurons exhibit molecular features and axonal 
projection patterns associated with corticothalamic or corticocortical neuron 
subtypes (Chen et al., 2005; Chen et al., 2008; Chen J et al., 2005). Previous 
reports (Diao et al., 2018; Komuta et al., 2007), and our current study show 
that in Fezf2-/- mice, corticothalamic neurons also exhibit defects in gene 
expression and axonal projections. We found that Fezf2 cko corticothalamic 
neurons showed increased expression of certain subcerebral neuronal genes 
such as BCL11B and the truncated FEZF2, indicating that corticothalamic 
neurons partially assume the molecular identity of subcerebral neurons in the 
absence of Fezf2 function. Together these results suggest that FEZF2 inhibits 
the expression of distinct and specific target genes in subcerebral neurons 
and in corticothalamic neurons, and by doing so FEZF2 prevents each class 
of neurons from adopting an alternate neuronal subtype identity. Consistent 
with this, the Fezf2-EnR allele rescued the molecular identities and axonal 
projections of both the subcerebral and corticothalamic subtypes in Fezf2-/- 
mice.  
  How does FEZF2 function as a transcriptional repressor? One 
possibility is that FEZF2 binds to an enhancer or promoter sequence and 
physically prevents the binding of a transcriptional activator. Another 
possibility is that the binding of FEZF2 to an enhancer or promoter recruits 
 
 
56 
additional transcriptional co-repressor(s) and together they actively repress 
gene expression. In Nex-Cre; Fezf2Flox/-l mice, a truncated FEZF2 protein 
consisting of just the DNA binding domain was expressed, yet in these mice 
subcerebral and corticothalamic neurons and their axons showed similar 
defects as in Fezf2-/- null mutant mice (Figure 1 and Supplemental Figure 1). 
This result indicates that the N-terminal half of the FEZF2 protein is essential 
for its transcriptional repressor function, likely by recruiting transcriptional co-
repressors, and that FEZF2 is unlikely to repress gene expression simply by 
blocking the binding of a transcriptional activator.  
Indeed, FEZF2 contains an EH1 motif, which can recruit TLE family 
transcription co-repressors. The co-expression of FEZF2 and TLE4 in 
corticothalamic neurons suggests that TLE4 may be one of its co-repressors. 
Similar to Fezf2-/- mice, corticothalamic neurons in Tle4-/- mice showed 
increased expression of genes associated with subcerebral neurons, 
indicating that TLE4 is involved in refining the molecular identity of 
corticothalamic neurons by preventing high level expression of some 
subcerebral neuronal genes. We found that the FEZF2-EnR allele, which 
does not depend on TLE family transcription co-repressors for its function, 
prevented the high expression levels of subcerebral neuronal genes and 
restored the functional properties of corticothalamic neurons in Tle4-/- mice. 
These results support the conclusion that FEZF2 and TLE4 together repress 
the expression of FEZF2, BCL11B and BHLHB5 in corticothalamic neurons. 
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However, the reduced expression of corticothalamic neuronal genes such as 
FOG2 and FOXP2 in Tle4-/- mice was not rescued by the Fezf2-EnR allele. 
Furthermore, although corticothalamic axons were missing in Fezf2-/- mice, 
they were present in Tle4-/- mice. Thus, although FEZF2 and TLE4 together 
refine the molecular differentiation and function of corticothalamic neurons, 
each plays additional independent roles. The identity of possible co-
repressor(s) for FEZF2 in subcerebral neurons remains unknown. 
Recent progress and our current study show that the subtype identity 
of a cortical projection neuron is specified in the postmitotic stage. Multiple 
transcription factors, including Tbr1 (McKenna et al., 2011; Han et al., 2011), 
Sox5 (Kwan et al., 2008; Lai et al., 2008),  Fezf2 (Chen et al., 2005; Chen et 
al., 2008; Chen J et al., 2005 ) , and the chromatin remodeling protein Satb2 
(Alcamo et al., 2008; McKenna et al., 2015), are essential for specifying 
cortical projection neuron subtype identities . A common phenotype of mice 
with mutations in these genes is that the affected neuronal subtypes exhibit 
gene expression profiles and axonal projection patterns associated with 
alternate neuronal subtypes. This suggests that TBR1, SOX5, and SATB2 
likely also function as selective repressors in their respective neuronal 
subtypes to inhibit expression of genes associated with alternate identities. In 
the future, it will be important to test whether these proteins act as 
transcriptional repressors, activators, or both, in the context of cortical 
projection neuron subtype specification. Another common feature shared by 
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the Tbr1, Sox5, and Satb2 genes is that all are expressed in postmitotic 
neurons. Although Fezf2 is expressed by both cortical RGCs and deep-layer 
neurons, our results indicate that it is required in postmitotic neurons for 
specifying cortical neuron subtype identities. These results suggest that 
projection neuron subtype-specific features are established through 
repressing genes associated with alternate subtype identities during 
postmitotic neuronal differentiation. 
Although different subtypes of cortical projection neurons have distinct 
morphologies, axonal projection patterns, and molecular profiles, they share a 
common cortical regional identity and use glutamate as an excitatory 
neurotransmitter. A fundamental question in brain development is whether a 
single genetic program specifies both the pan-cortical excitatory neuron 
identity and the subtype-specific identity of a cortical projection neuron, or 
these features are specified by distinct genetic programs. Projection neuron 
subtype identities are mis-specified in Fezf2-/-, Tbr1-/-, Sox5-/- and Satb2-/- 
mice, but mutant cortical neurons maintain their glutamatergic identity and fail 
to acquire molecular features associated with GABAergic neurons. Thus, the 
subtype identity genes are not required for the adoption of a pan-cortical 
glutamatergic identity. 
A different set of transcription factors, expressed in the RGCs and/or 
intermediate progenitors, including Pax6, Tlx, Dmrt5, Dmrt3, Emx2, Ngn1, 
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and Ngn2, are essential for establishing the regional and glutamatergic 
identities of cortical projection neurons (Konno et al., 2019; Desmaris et al., 
2018; Kroll et al., 2005; Schuurmans et al., 2004). Based on our results and 
previous studies, we propose that the common vs. unique characteristics of 
cortical projection neuron subtypes are specified sequentially during 
development. At early stages of corticogenesis, transcription factors 
expressed in cortical RGCs and/or intermediate progenitors (including Pax6, 
Tlx, Dmrt5, Dmrt3, Emx2, Ngn1, and Ngn2) act in parallel pathways to ensure 
the generation of cortical glutamatergic projection neurons and prevent the 
production of ventral GABAergic neurons (Konno et al., 2019; Desmaris et al., 
2018; Kroll et al., 2005; Schuurmans et al., 2004). As postmitotic cortical 
neurons begin to migrate and differentiate, genes such as Fezf2, Tbr1, Sox5, 
and Satb2 repress the expression of genes associated with alternate 
neuronal subtype identities to establish specific subtype-specific identities. In 
the future, it will be necessary to rigorously test whether the proteins encoded 
by these genes function as transcriptional repressors or activators during 
development, and to determine how the expression of neuronal subtype 
identity genes is initially activated. Answers to these questions will be 
invaluable for designing novel and efficient strategies for using directed 
differentiation or trans-differentiation methods to repair damaged brain circuits 
in disease and injury. 
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Materials and Methods 
Animals 
Experiments were performed according to protocols approved by the 
Institutional Animal Care and Use Committee at University of California at 
Santa Cruz and at University of Arizona College of Medicine Phoenix, and 
were performed in accordance with institutional and federal guidelines. 
Experiments performed at Fudan University were in accordance with 
institutional guidelines.  
We generated the Tle4/Grg4 mutant allele by inserting a LacZ-ires-
Plap cassette in the intron after the exon 4 of the Tle4 gene, using the 
targeted gene trap strategy (Friedel et al., 2005). Southern hybridization was 
performed to screen the E14a ES cell clones and identify the correct 
targeting.  
The bacterial artificial chromosome (BAC) clone RP23-141E17 was 
modified by inserting the cDNA encoding the ENGRAILED transcriptional 
repressor domain (EnR) fused with the DNA binding domain of FEZF2, 
followed by the SV40 polyadenylate site (Fezf2-EnR), at the start codon of the 
mouse Fezf2 gene. The BAC DNA was purified and sequenced, and used for 
injection to generate the Fezf2-EnR transgenic mouse line.  
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The day of the vaginal plug detection was designated as E0.5. The day 
of birth was designated as P0. The genders of the embryonic and early 
postnatal mice were not determined. 
PLAP staining 
Human placental alkaline phosphatase (PLAP) staining was performed 
as described previously (Chen et al., 2005).  
 
Immunohistochemistry 
4% paraformaldehyde was delivered to mice via trans-cardiac 
perfusion. Brains were post-fixed in 4% paraformaldehyde, 0.1% saponin, 
and PBS for 24 hours at 4°C, followed by cryoprotection in 30% sucrose in 
PBS. Immunohistochemistry was performed using standard protocols. Briefly, 
twenty-five-μm-thick brain sections were permeabilized with 0.03% Triton X-
100 in PBS for 30 min. Slides were then immersed in citrate buffer (10mM 
citric acid monohydrate, 0.05% Tween-20, pH 6.0), brought to a boil in a 
microwave and rested for 1 hour at RT. Slides were then incubated in a 
blocking buffer (5% donkey serum, 0.03% Triton X-100 in PBS) for 30 
minutes. Blocking buffer was removed, and the sections were incubated with 
primary antibodies (diluted in the blocking buffer) for 24 hours at 4°C. The 
following primary antibodies were used in this study: GFP (Chicken, Aves 
Labs GFP-1020), BCL11B (Rat, Abcam ab18465), TBR1 (Rabbit, Abcam 
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ab31940), SOX5 (Rabbit, Abcam ab94396), FEZF2 (Rabbit, IBL F441), TLE4 
(Mouse, Santa Cruz Biotechnology sc-365406), FOXP2 (Rabbit, Abcam 
ab16046) , ZFPM2 (Rabbit, Santa Cruz Biotechnology), B-GAL (Chicken, 
Abcam ab9361), activated caspase 3 (Rabbit, Cell Signaling Technology 
#9661), BHLHB5 (Goat, Santa Cruz Biotechnology sc-6045), SATB2 (Rabbit, 
Abcam ab34735), FOSL2 (Rabbit, Sigma HPA004817) , and GAPDH 
(Covance, MMS-580S), The sections were washed in PBS, and incubated 
with secondary antibodies conjugated to Alexa 488, Alexa 546, or Alexa 647 
for 2 hours at room temperature. Secondary antibodies were from Jackson 
ImmunoResearch and Invitrogen. Finally, the sections were counterstained 
with DAPI for 5min before being mounted in Fluoromount-G. 
In situ hybridization 
In situ hybridization was performed using a previously published 
protocol19. In brief, digoxigenin-labeled probes used in this study were made 
from cDNAs amplified by PCR using the following primers: 
Gene Forward Primer 5’ à 3’ Reverse Primer 5’ à 3’ 
Tcerg1l CTCTCCCCACTGTGGTATTAGC CAGAACTATTTCCCCTCGTGAC 
Ldb2 CACCTGATTACGCTGTCCATAG AAGTTCAACACACGAGGGAGAT 
Tox GCTTTGTTCTTTCGTGATACCC CGGGTTGAAGAGTAAATCCTTG 
Ctgf AAATCGCCAAGCCTGTCAAG GGCACTGTGCGCTAATGAAC 
Cryab CTCAGCCCTGCCTGTGTT ATCTGGGCCAGCCCTTAG 
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Amplified DNA fragments were ligated into pGEM-T Easy (Promega) 
plasmids, transformed into competent E. coli cells, and plated overnight on 
LB+Agar+Ampicillin plates. Colonies were picked, grown overnight in 3 mL 
LB+Ampicillin, and purified via miniprep kits (Sigma-Aldrich). Purified 
plasmids were sequenced to ensure sequence fidelity, and to determine 
insert orientation. Plasmids were then linearized with restriction enzymes from 
New England Biotech, and in vitro transcription reactions were performed with 
either T7 (NEB) or Sp6 (Promega) RNA polymerases, depending on insert 
orientation, in the presence of DIG-labeled nucleotides (Sigma-Aldrich). 
Tissue was prepared as previously described by Guo et al. (2013), and 
treated with DIG-labeled probes overnight at 65° C. Slides were developed 
with NBT/BCIP stock solution (Sigma-Aldrich) 
EdU labeling 
Timed pregnant Tle4+/- mice were injected with a single dose of EdU 
(50mg/kg body weight; Thermo Fisher Scientific, E10187) at E12.5 or E13.5. 
Brains were collected at P7. EdU was detected via a click-chemistry reaction 
containing the following reagents per 1 ml of reaction: 950ul 100mM Tris PH 
7.4, 40ul 100 mM CuSO4, 10ul 200 mg/mL sodium ascorbate, and 1ul azide 
488 or 555. Tle4-/- and littermate Tle4+/- control mice were analyzed.  
Anterograde tracing using AAV 
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0.25 µl AAV2-CMV-mCherry virus (Vector Biosystems Inc.) were 
injected into the M1, S1 or V1 of Tle4-/- and littermate control Tle4+/- or Tle4+/+ 
mice at P21. The brains were collected at P35 and sectioned at 50-µm 
thickness.  
Retrograde tracing 
Retrograde tracing was performed using Alexa Fluor 555-conjugated 
cholera toxin subunit b (CTB) injections. 8 mg/ml CTB in PBS was used for all 
injections, and CTB solution was injected through a pulled glass pipet 
attached to a Picospritzer III (Parker). P4 mice were anesthetized, the 
pyramidal decussation was identified visually, and 1 µl CTB was injected. 0.2 
to 0.5 µl CTB was injected into S1 in anesthetized P4 mice and injection sites 
were confirmed after brain collection at P7.  Corticothalamic neurons were 
labeled by CTB injection (0.2 µl) into the thalamus at P21 (coordinates: A/P -
1.3 mm, M/L 3 mm, Z 3.15 mm) and injection sites were confirmed after brain 
collection at P28.  
Cloning of the pCAG-Fezf2, pCAG-Fezf2-EnR, and the pCAG-Fezf2-VP16 
expression plasmids 
The cloning of pCAG-Fezf2 plasmid was reported previously (Chen et 
al., 2005). The EnR and VP16 plasmids were obtained from Dr. Thomas 
Jessell (Columbia University). The cDNA for DNA binding domains of FEZF2 
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was amplified using primers 5’-
GATCGAATTCTCAGCTCTGAACTGTCCTGGCTAGGTC-3’ and 5’-
GATCGGATCCGCCGCCGCCATGGAGCCCCGGCCTGCTGCGTTAGAGGC-3’. 
The cDNA for the EnR domain was amplified using primers 5’-
GATCGATATCAAGCTTGGGCTGCATAGATCCCAG-3’ and 5’-
GATCGGATCCGCCGCCACCATGGAGTTCCGCGATGCCCTGGAGGATCG
C-3’. The cDNA for VP16 domain was amplified using primers 5’-
GATCGGATCCGCCGCCACCATGGCCCCCCCGACCGATGTCAGCCT-3’ 
and 5’-GATCGATATCCCCACCGTACTCGTCAATTCCAA-3’. The amplified 
DNA fragments were ligated into pCAG vector, using NotI and XhoI restriction 
sites. Sanger DNA sequencing was performed to ensure no mutation was 
generated during the cloning. 
 
In utero electroporation 
In utero electroporation experiment was performed according to a 
published protocol (Chen et al., 2005). In utero electroporation (IUE) of wild-
type CD-1 embryos was performed at E15.5. Plasmids pCAG-Fezf2, pCAG-
Fezf2-EnR, or pCAG-Fezf2-VP16 were mixed with pCAG-EGFP (Addgene 
#11150) (final concentration of 1-2 μg/μl at a molecular ratio of 3:1, 0.5μl each 
embryo) and 0.05% Fast Green (Sigma), and injected into the lateral ventricle 
of embryos using a beveled pulled glass micropipette. The control brains 
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were electroporated with pCAG-EGFP plasmids alone. Five electrical pulses 
(duration: 50 ms) were applied at 35V across the uterine wall with a 950 ms 
interval between pulses. Electroporation was performed using a pair of 7-mm 
platinum electrodes (BTX, Tweezertrode 45-0488, Harvard Apparatus) 
connected to an electroporator (BTX, ECM830). The electroporated brains 
were collected at P5. 
Image acquisition and analysis 
Images for quantitative analyses were acquired with a Zeiss 880 
confocal microscope. Laser power and gain were adjusted until <1% of pixels 
were saturated. Cell counting was performed on single z-slices with FIJI. Z-
slices were divided into 500 µm or 250 um wide regions and split into equally 
sized bins. Individual channels were adjusted with auto threshold “Moments,” 
or a manual threshold was applied to discern BCL11B high versus low 
expressing cells. The dilate, erode, and watershed functions were 
sequentially used before particles were analyzed with a circularity of 0.3-1.0 
and size exclusion of >1µm. Brightfield images were acquired with a Zeiss 
AxioImager Z2 widefield microscope with a Zeiss AxioCam 506 (color) 
camera.  
Statistical analysis was performed using GraphPad Prism 5.0, or R. 
Only single Z-slice confocal images were used in cell quantifications. For 
each brain, the number of marker+ cells in the cortex were quantified in a 500- 
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or 250-μm-wide region from 3 sections each for S1, M1 and V1 areas. Care 
was taken to match the anterior-posterior, medial-lateral positions for the 
chosen areas between the mutant and control genotypes. For each genotype 
and each age, 3 different brains were analyzed. Data are shown as mean ± 
SEM and statistical significance for multiple comparisons was determined 
using the ordinary one-way ANOVA test followed by Tukey’s multiple 
comparisons test. Statistical significance for single comparisons was 
determined using the unpaired t-test. Significance was set as * for p < 0.05, ** 
for p < 0.01, *** p < 0.001 for and ****p<0.0001 all significance tests. 
RNA-seq analysis of Tle4-/- and Fezf2Plap/Plap cortices at P0 
Cortices were dissected from P0 Tle4-/- and littermate control Tle4+/+ 
mice, P0 Fezf2Plap/Plap and littermate Fezf2+/+ mice (n=3 for each genotype). 
Total RNA from each pair of cortical hemisphere was isolated using the 
RNAesay kit (Qiagen) and used to prepare RNA-seq libraries (Illumina RNA 
Truseq Library Prep protocol). Libraries were paired-end (50 nucleotides per 
end) sequenced on the Illumina Hiseq2000 platform. The sequences were 
processed and analyzed for differential expression as previously described 
(Betancourt et al., 2013). The RNA-seq data for the Fezf2Plap/Plap and control 
cortices, and for the Tle4-/- and control cortices can be accessed using 
GEOXXX and GSE142269. 
Electrophysiology and neuronal morphology 
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Whole cell recording was conducted in the primary somatosensory 
cortex (V1). To label layer 6 corticothalamic neurons, 50nl of retrobeads 
(Lumafluor) were injected into the POM nucleus unilaterally at least 24h prior 
to recording.  350-µm slices were made after a block cut of the posterior brain 
with a 45° angle to the mid-sagittal plane. Slices were cut in ice-cold ACSF 
(containing 126 mM NaCl, 2.5 mM KCl, 26 mM NaHCO3, 2 mM CaCl2, 1 mM 
MgCl2, 1.25 mM NaH2PO4, and 10 mM glucose saturated with 95% O2 and 
5% CO2). Slices were incubated at 32°C for 30 min before being transferred 
to the recording chamber. Beads+ neurons with soma in layer 6 were 
identified under a 60X objective (NA = 0.9). Only neurons with their soma at 
least 50 µm below the slice surface were targeted for whole cell recordings. 
The internal electrode solution contains: 130 mM K-gluconate, 10 mM 
HEPES, 4 mM KCl, 0.3 mM GTP-Na, 4 mM ATP-Mg, 2 mM NaCl,1 mM 
EGTA and 14 mM phosphocreatine (pH 7.2, 295-300 mOsm). 0.15% (W/V) 
biocytin was added when neuron morphology data were desired.    
 
Neuronal signals were amplified using a MultiClamp 700B amplifier 
(Molecular Devices, Forster City, CA), low-pass filtered at 1 kHz (current) or 
10 kHz (voltage signals), and digitized at 20 kHz using a Digidata 1440A 
interface and pClamp 10.6 (Molecular Devices). mEPSCs were measured 
with D-AP5 (50 µM, Tocris) and tetrodotoxin (TTX, 1µM, Tocris) included in 
the ACSF. To measure mIPSCs, TTX (1 µM) and CNQX (10 µM) were 
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included and a symmetrical [Cl-] electrode internal solution (containing: 125 
mM KCl, 2.8 mM NaCl, 2 mM MgCl2, 2 mM Mg2+-ATP, 0.3 mM Na3GTP, 10 
mM HEPES, 1 mM EGTA and 10 mM phosphocreatine, pH 7.25, 
~300 mOsm) was used.  In experiments where neuronal excitability was 
measured, a series of current steps (-100 to 500pA in 50 pA increment) were 
injected, and numbers of AP firing were manually quantified.  
 
To reconstruct neuronal morphologies, slices were fixed in 4% PFA 
overnight, followed by incubation with avidin-Alexa 488 (Invitrogen) for 24 h in 
PBS containing 0.2% Triton X-100. Slices were washed and mounted on 
slides with a 350-µm spacer to prevent crushing the tissue. Neuronal dendritic 
arbors were acquired by collecting Z-stack images on a confocal microscope 
(Zeiss LSM 710). Maximal projection images were imported into FIJI/ImageJ, 
and neurite arborization and Sholl analysis (Sholl, 1953) were done using the 
Simple Neurite Tracer plugin.  Due to the length of apical dendrites, dendrites 
were frequently cut off. Therefore, only basal dendrites were used for Sholl 
analysis. Morphometric features extracted included dendritic arbor, length, 
and number of intersections at various distances from soma.  For dendritic 
spine analyses, Z-stacks of spines from the basal dendrites (100-450 µm 
away from soma) were collected with a 63x objectives (Plan-Apochromat, NA 
1.4).  512×512 pixels with 4× digital zoom and 0.2 µm Z step size were used 
for Z-stack acquisition. Imaris software (V8.02, Bitplane, South Windsor, CT) 
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was used to measure spine head diameter, length, and density (Peng et al., 
2016). 
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Chapter 3: Conclusions and Future Directions 
 
In the previous chapter, I have presented and interpreted the results of 
experiments focused on understanding how Fezf2 and Tle4 function to 
specify and maintain corticothalamic projection neuron subtype in the 
mammalian cerebral cortex. More specifically, we have shown that in 
corticothalamic neurons, FEZF2 and TLE4 function together to co-regulate 
the molecular differentiation, dendritic morphology, and function of these 
neurons. In doing so, we have also generated three novel mouse lines, Fezf2-
flox, Fezf2-BAC-EnR and Tle4 KO, which will be useful for future studies as 
well. Overall, this work has shed light onto the intricate pathways required for 
the proper generation and maintenance of layer 5 and 6 excitatory projection 
neurons.  
 
Insight into the function of TLE4 in CThPNs 
 
 Despite the widely accepted fact that TLE4 is highly expressed in 
CThPNs, the role it plays in the generation, maintenance, or function of these 
neurons was completely unknown until now. Through the generation of the 
novel transgenic Tle4 knockout mouse line, I was able to meticulously 
investigate the various roles that TLE4 may play in CThPNs. Through the 
results shown and discussed earlier, we now have a much deeper 
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understanding of the role TLE4 in this cell type. The striking similarities 
between the phenotypes of layer 6 neurons between the Tle4 and Fezf2 
knockout mice then prompted us to investigate whether these two proteins 
interact to functionally regulate transcription, thus specifying neuronal 
subtype. 
The results of this study have also begun to tease apart the 
mechanisms FEZF2 uses to specify specific corticofugal subtype identity 
within the developing cerebral cortex. Specifically, I show that TLE4 is highly 
expressed in postmitotic CThPNs and is required to specify the molecular 
characteristics of these neurons, and it does so through binding FEZF2 and 
repressing SCPN genes. The interaction of FEZF2 and TLE4 was also shown 
to regulate the electrophysiological properties of CThPNs. These results 
provide convincing evidence that the cooperative transcriptional repression of 
SCPN genes by FEZF2 and TLE4 in newborn postmitotic neurons is 
necessary for proper cortical development. CThPNs are important for the 
proper processing and integration of sensory information, and their 
dysfunction has been implicated in epilepsy (Mattson, 2003).  
The gene Tbr1 (T-box, Brain, 1) codes for a transcription factor that is 
also highly expressed in CThPNs. Among other defects, CThPNs are 
completely absent in the cortex upon the deletion of Tbr1. Thus, Tbr1 is often 
considered to be the master regulator of CThPN development. Interestingly, 
when we performed ChIP-seq for the TBR1 protein in the mouse cortex, we 
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saw a large binding peak just upstream of the Tle4 gene (Darbandi et al., 
2018). Additionally, through bulk RNA sequencing of the cortices of Tbr1 KO 
mice, we saw a severe reduction of Tle4 expression levels compared to 
control cortices (Darbandi et al., 2018). However, these two results were not 
discussed or interpreted in the manuscript, I have just noted these results 
from the data. I also performed immuno-staining for TLE4 protein in the Tbr1 
KO cortex, which showed a very dramatic reduction in the number of TLE4 
positive neurons, (unpublished). These data combine to suggest that Tbr1 
likely acts to promote Tle4 expression in the transcriptional pathway of 
CThPN fate specification. Despite these clear preliminary results, this claim 
should be taken merely as a hypothesis, as it has yet to be adequately tested. 
I do, however, believe that testing and confirming this hypothesis will likely 
hold valuable information relevant to human health, as the proper function of 
CThPNs has been implicated in mental disorders as mentioned earlier. 
 
Future implications in SCPN fate-specification by Fezf2 
 
 Previously, it was unknown whether Fezf2 specified SCPN identity in 
RGCs or newly born postmitotic neurons. Through our innovative use of 
transgenic strategies is mice, we were able to reliably and thoroughly tease 
apart this fundamental question. I believe results such as these truly 
emphasize the necessity of the deep and focused research into the 
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transcriptional regulation mechanisms in specific cell subtypes. Many studies 
have made claims about the broad functions of transcription factors, but our 
results clearly show that a single transcription factor can play extremely 
different roles dependent upon the cell type they are expressed in. It will be 
important to not only understand which transcription factors function 
differently in alternate progenitor and neuronal subtypes, but to also actually 
decipher the mechanisms that the transcription factors utilize to tightly control 
target gene expression levels. Recently, Fezf2 has been implicated in a wide 
variety of human disorders from the promotion of bladder cancer by regulating 
the NF-KB signaling pathway (Chen et al., 2018), to acting as a key regulator 
of autoimmunity in medullary thymic epithelial cells to eliminate T cells that 
respond to self-antigens (Takayanagi et al., 2015). Thus, working towards a 
complete understanding of Fezf2 as a transcriptional regulator on a molecular 
level will prove invaluable across many disciplines. 
 Upon interpreting the results presented above, many new and exciting 
questions have been raised. I believe that in the future it will be necessary to 
carefully isolate specific cell subtypes with techniques such as fluorescently 
activated cell sorting (FACS) followed by mass spectrometry (MS), in order to 
perform in-depth analysis of proteins that interact with FEZF2 in specific 
cellular subtypes. With recent advances in the applications of mass 
spectrometry, it is becoming more and more feasible to perform proteomic 
analysis on very small numbers, or even single cells, such as in the case of 
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SCoPE-MS (Budnik et al., 2018). These advanced technologies are still very 
resource intensive, but as they become more accessible, they will be 
extraordinarily useful for protein analyses such as the one I have just 
mentioned. Understanding the proteins other than TLE4 that interact with 
FEZF2 will provide useful insight into the function of this transcription factor 
that has been repeatedly implicated as a key player in a wide variety of 
human disorders affecting different cell types. This will vastly broaden the 
scope of potential targets when designing therapeutics for diseases in which 
FEZF2 is implicated. 
 Once we have a better understanding of the protein structures formed 
with FEZF2, the next step will be to again isolate specific cell subtypes and 
perform chromatin immunoprecipitation followed by RNA sequencing (ChIP-
seq) for FEZF2 and its interacting proteins. This will inform not only the genes 
FEZF2 binds and regulates, but also it will inform which region of the gene 
FEZF2 typically binds. Again, this type of knowledge will open up new 
avenues for the development of therapeutics for the devastating diseases in 
which FEZF2 is implicated. Sometime in the near future, as DNA modifying 
technologies such as CRISPR-Cas9 continue to be optimized, it will be 
possible to target and modify very specific regions within the human genome. 
Thus, the simultaneous investigation into various regulatory DNA sequences 
and the proteins that bind them, such as TLE4 and FEZF2, will be essential 
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for the continuous advancement of effective and individualized medical 
treatment options. 
 
Implications in human health 
 
 One potential application of this work is in regenerative medicine. 
Currently, there is much hope and effort surrounding stem cell therapies for 
the treatment of degenerative diseases such as Alzheimer’s, Parkinson’s, and 
ALS. Understanding the mechanisms behind the generation and maintenance 
of the neuronal subtypes affected in these devastating diseases is 
fundamental to continually advance the efficacy of therapeutics aimed at 
these diseases. In order to effectively use stem cell replacement therapies, 
we must be able to efficiently and specifically generate distinct neuronal 
subtypes that are lost or damaged in these disorders. To do this, we must 
have a deep understanding of the molecular mechanisms underlying these 
fate decisions in order to generate neurons that are as similar to healthy 
endogenous neurons as possible. In this study, we show that upon Tle4 
deletion, corticothalamic neurons still project to the thalamus, but their 
electrophysiological properties are significantly affected. One interesting 
observation I noticed during my experiments, but never fully analyzed, was 
that Tle4 mutant mice appeared to exhibit multiple behavioral abnormalities. 
For example, these mice would often be seen running in tight clockwise 
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circles and speed up when frightened. Also, it was noted that the Tle4 
knockout mice were more susceptible to audiogenic seizures than control 
mice. This is consistent with the findings that implicate defective 
corticothalamic neuron function in humans as a main contributor to epilepsy. 
This strongly exemplifies our need to continue to deeply investigate the 
molecular mechanisms underlying subtype specification and function. Despite 
the ability of CThPNs to reach the thalamus in Tle4 mutant mice, their 
dysfunction may lead to abnormal behavioral phenotypes. Without careful and 
thorough analysis, the initial results of this study could have been extremely 
misleading, which could be catastrophic in the context of regenerative stem 
cell transplant therapies. This implicates the need for an extremely thorough 
understanding of the molecular mechanisms involved in the proper generation 
and function of cortical neuron subtypes. In conclusion, this dissertation has 
not only confronted and convincingly corrected multiple common 
misconceptions, but has also uncovered novel mechanisms involved in the 
transcriptional regulation of cortical neuron subtype specification. 
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